MoneyWorks4Me

Sanofi India - Quaterly Results

23 Feb 2023 Evaluate
Revenue showed a marginal decline at Rs. 6719.00 millions. For the quarter ended December 2022, as compared to corresponding quarter of last year.Net Profit recorded in the quarter ended December 2022 rise to 44.80% to Rs. 1309.00  millions  compared to R. 904.00 millions in corresponding previous quarter.Operating Profit saw a handsome growth to 1869.00 millions from 1435.00 millions in the quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202212 202112 % Var
Sales 6719.00 6879.00 -2.33 27701.00 29566.00 -6.31 27701.00 29566.00 -6.31
Other Income 200.00 163.00 22.70 715.00 744.00 -3.90 715.00 744.00 -3.90
PBIDT 1869.00 1435.00 30.24 7759.00 8369.00 -7.29 7759.00 8369.00 -7.29
Interest 4.00 4.00 0.00 17.00 18.00 -5.56 17.00 18.00 -5.56
PBDT 2004.00 1431.00 40.04 9062.00 13243.00 -31.57 9062.00 13243.00 -31.57
Depreciation 100.00 109.00 -8.26 419.00 667.00 -37.18 419.00 667.00 -37.18
PBT 1904.00 1322.00 44.02 8643.00 12576.00 -31.27 8643.00 12576.00 -31.27
TAX 595.00 418.00 42.34 2437.00 3132.00 -22.19 2437.00 3132.00 -22.19
Deferred Tax -35.00 -12.00 191.67 -15.00 -228.00 -93.42 -15.00 -228.00 -93.42
PAT 1309.00 904.00 44.80 6206.00 9444.00 -34.29 6206.00 9444.00 -34.29
Equity 230.00 230.00 0.00 230.00 230.00 0.00 230.00 230.00 0.00
PBIDTM(%) 27.82 20.86 33.35 28.01 28.31 -1.05 28.01 28.31 -1.05
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..